Table 3. Harms and benefits of cervical screening starting from age 20 compared with starting from age 25.
| Age group (years) | 100 000 women invited from age 20 years | 100 000 women invited from age 25 years | Excess in women invited from age 20 years |
|---|---|---|---|
|
Screening tests | |||
| 20–24 | 134 961 | 0 | |
| 25–26 | 54 857 | 70 710 | |
| Sum |
189 818 |
70 710 |
119 108 |
|
Non-negative test resultsa | |||
| 20–24 | 23 968 | 0 | |
| 25–26 | 6988 | 10 558 | |
| Sum |
30 956 |
10 558 |
20 398 |
|
Referred to colposcopy | |||
| 20–24 | 10 082 | 0 | |
| 25–26 | 3346 | 5252 | |
| Sum |
13 427 |
5252 |
8175 |
|
Treated (excision, ablation) | |||
| 20–24 | 3885 | 0 | |
| 25–26 | 1606 | 2657 | |
| Sum | 5491 | 2657 | 2834 |
The number of non-negative screening episodes is obtained by multiplying the number of screens by the proportion of women with a non-negative (borderline changes or worse) test.